Adjuvant radiotherapy does not affect hemostasis
Cancer is associated with increased risk of venous thromboembolic disease. Venous thromboembolic disease accounts for a substantial addition to morbidity and mortality rates in cancer patients and is the second leading cause of death in cancer patients, exceeded only by the underlying cancer. Only f...
Main Authors: | Katrine Munk Begtrup, Johanne Andersen Hojbjerg, Birgitte Vrou Offersen, Anne-Mette Hvas |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-04-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2018.1448378 |
Similar Items
-
Narrative Review of the Post-Operative Management of Prostate Cancer Patients: Is It Really the End of Adjuvant Radiotherapy?
by: Vincent Bourbonne, et al.
Published: (2022-01-01) -
Hibernation and hemostasis
by: Edwin L. De Vrij, et al.
Published: (2023-06-01) -
Adjuvant Radiotherapy after Surgical Excision in Keloids
by: Jeong Won Lee, et al.
Published: (2021-07-01) -
Peculiarities of hemostasis in patients with COVID-19
by: Anna I. Kalinskaya, et al.
Published: (2022-08-01) -
SYSTEM OF HEMOSTASIS AND ATHEROGENESIS
by: A. A. Gromov, et al.
Published: (2016-09-01)